Living Cell Technologies Ltd. (AU:1AI) has released an update.
ALGORAE PHARMACEUTICALS LIMITED has announced the application for quotation of new securities on the ASX, with 30,277 ordinary shares fully paid to be quoted under the code 1AI. The announcement, made on May 16, 2024, details the company’s agreement with the ASX Listing Rules for the issuance of these securities.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.
